Recent Finacing
Recent Raise
Pathios Therapeutics is an Oxford-based drug discovery company developing small-molecule GPR65 inhibitors to modulate pH-driven immune cell polarization in acidic tumor microenvironments for cancer and autoimmune therapies.
